Implementation report on the Commission Communication on Rare Diseases published September 5, 2014. Read more...
Act now: Contact your MEP and ask them to support and ask ECDA's questions to Commissioners designate
PBC is a rare liver disease that primarily results from autoimmune destruction of the bile ducts. Women account for about 90% of PBC cases. Read more...
Now 4063 members from 106 countries
Issue 7 (April 2012) Management of Hepatocellular Carcinoma

These guidelines result from a joint collaboration between the European Association for the Study of the Liver (EASL) and the European Organization for Research and Treatment of Cancer (EORTC).

The EASL–EORTC Clinical Practice Guidelines provide common guidelines for the management of hepatocellular carcinoma (HCC) and define the use of surveillance, diagnosis, and therapeutic strategies recommended for patients with this type of cancer.

NEW! The EASL–EORTC Clinical Practice Guidelines on management of hepatocellular carcinoma (HCC) are now available in Spanish, Portuguese, Russian and Chinese.